ArticleBMC cancer2017

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.

Jesper Andreas Palshof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.